COVID-19: the effects on the practice of pediatric emergency medicine

David M Walker1, Victorio R Tolentino2

  • 1Chief, Pediatric Emergency Medicine, Department of Pediatrics, Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack.

Insights

Pediatric emergency departments adapted operations and care during COVID-19 due to patient volume shifts and infection control needs. This highlights the resilience of pediatric emergency medicine in public health crises.

Area of Science:

  • Emergency Medicine
  • Public Health
  • Pediatrics

Background:

  • The COVID-19 pandemic significantly impacted healthcare systems globally.
  • Pediatric emergency departments (PEDs) faced unique operational and clinical challenges.
  • Understanding these challenges is crucial for future preparedness.

Purpose of the Study:

  • To survey pediatric emergency department leaders in North America regarding pandemic-related changes.
  • To identify operational, infrastructural, staffing, and clinical care adjustments in PEDs.
  • To assess the impact on academic training and provider well-being.

Main Methods:

  • An informal survey was conducted among 65 leaders of pediatric emergency departments.
  • Respondents represented 30 U.S. states and 4 Canadian provinces.
  • The survey focused on changes implemented due to the COVID-19 pandemic.

Main Results:

  • PEDs implemented changes in operations, infrastructure, staffing, and clinical care.
  • Key drivers included reduced pediatric volumes, increased adult patient surges, infection control, and financial factors.
  • Pandemic effects on academic training programs and provider wellness were also reported.

Conclusions:

  • Pediatric emergency medicine departments demonstrated significant adaptability during the COVID-19 public health emergency.
  • These findings offer a snapshot of resilience and coping strategies in PEDs.
  • The study underscores the need for robust support systems for PEDs during crises.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
187
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
391
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
123
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
370
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
164